text
stringlengths
16
2.35k
tokenCount
int64
5
450
pageStart
int64
1
43
pageEnd
int64
1
43
hash
stringlengths
64
64
Prevalence of functioning adrenal incidentalomas: a systematic review and meta-analysis. J Clin Endocrinol Metab . 2023;108(7):1813-1823. Seccia TM, Letizia C, Muiesan ML, et al . Atrial fibrillation as pre - senting sign of primary aldosteronism:
76
38
38
d02e04b8cf55263e13d5a7e96e16e3cd90473e71a891ea130b88997c4eb59512
results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study. J Hypertens . 2020;38(2):332-339. 2490 The Journal of Clinical Endocrinology & Metabolism , 2025, Vol. 110, No.
68
38
38
ea3981d5a8ce4cb82cbbc357960c440692dca69467f1b6fa49021d45b3018de1
9 Downloaded from https://academic.oup.com/jcem/article/110/9/2453/8196671 by University of Wisconsin System user on 20 February 2026
40
38
38
86d3541f16c4cf3f3990fa58d424f397068a88b4c212a690d7cd989da5201309
Murase K, Nagaishi R, Takenoshita H, Nomiyama T, Akehi Y, Yanase T. Prevalence and clinical characteristics of primary aldos - teronism in Japanese patients with type 2 diabetes mellitus and hypertension.
54
39
39
e3f9d4db39e71ab95067e729cc9f29400512a4695e18a57329b205ee1a5d1319
Endocr J . 2013;60(8):967-976. Hu Y, Zhang J, Liu W, Su X. Determining the prevalence of pri - mary aldosteronism in patients with new-onset type 2 diabetes and hypertension.
56
39
39
617916d3fdd7d61ea2e558d181fe0d3982ee5849abdd1837c14995467b67e882
J Clin Endocrinol Metab . 2020;105(4): 1079-1085. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension:
69
39
39
38bc0d6c89580e0a08a37fc807fcae10ea5c7515306c4ec23922c52a948bf84d
endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens . 2023;41(12):1874-2071.
41
39
39
e17e9f51a7899113df3beaab017bdaa34cb8e41eccc39f393c4c93b1c2a1292c
Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev . 2018;39(6): 1057-1088.
57
39
39
2fd8fc3d5f40401ea4376eda5cfe1bbca0b366bec6fdac067cc339f999bcd0d3
Mulatero P, Monticone S, Burrello J, Veglio F, Williams TA, Funder J. Guidelines for primary aldosteronism: uptake by pri - mary care physicians in Europe. J Hypertens . 2016;34(11): 2253-2257.
63
39
39
0ab82fcb17ada8a4ef322aa15d527faf0dea77ffb8e56dbfae86f62e66df9431
Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V. Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S.
47
39
39
5b4718af4c35bd5ffb666efc071554d259f19f2f8668f840eb190c12e1c2ce24
Veterans: a retrospective cohort study. Ann Intern Med . 2021;174(3):289-297. Hundemer GL, Imsirovic H, Vaidya A, et al.
41
39
39
343462e08cc9b0da44ea6cbd8224d6210e756195fd6f4e800273acb5a15eba39
Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study. Hypertension . 2022;79(1):178-186. Farah MH, Hegazi M, Firwana M, et al.
58
39
39
d8fb5c44660560e22b3ae29538330ab6dd62a94c8ddb6209f28728d826b64ccf
A systematic review supporting the endocrine society clinical practice guideline on management of primary aldosteronism. J Clin Endocrinol Metab . 2025;110(9):e2833-e2844. Murad MH, Liem RI, Lang ES, et al. 2019 sickle cell disease guide - lines by the American Society of Hematology: methodology, chal - lenges, and inn...
247
39
39
7b8b108b7df8a55160701bf7b860816d3ae8a50d643b15f5e974343fc7f9c07f
Clinical and genetic cor - relates of aldosterone-to-renin ratio and relations to blood pres - sure in a community sample. Hypertension . 2007;49(4):846-856. Brown JM, Robinson-Cohen C, Luque-Fernandez MA, et al. The spectrum of subclinical primary aldosteronism and incident hyper - tension: a cohort study. Ann Intern ...
99
39
39
5269c0955fde7aa07c1e80539118ab475e6583bf9964f7b925b47b123655e5dc
Meneton P, Galan P, Bertrais S, Heudes D, Hercberg S, Ménard J. High plasma aldosterone and low renin predict blood pressure in - crease and hypertension in middle-aged Caucasian populations.
52
39
39
1f1da7570c16919b45d270df83e4b85dcea2859a23d65064be95d5ef5692b993
J Hum Hypertens . 2008;22(8):550-558. Arnold N, Hermanns IM, Schulz A, et al. Renin, aldosterone, the aldosterone-to-renin ratio, and incident hypertension among normotensive subjects from the general population.
61
39
39
354f011228d39941714c151fce383a95dd41941ee3808cb7adc1662b0316fbc1
Cardiovasc Res . 2023;119(1):294-301. Hu J, Shen H, Huo P, et al. Heightened cardiovascular risk in hypertension associated with renin-independent aldosteronism versus renin-dependent aldosteronism:
57
39
39
6c3a7637763bbe989664e8c7a746fcd28ea7bed92e7ad68b00f0e4df0e713c25
a collaborative study. J Am Heart Assoc . 2021;10(24):e023082. Lieb W, Larson MG, Benjamin EJ, et al. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham heart study. Circulation . 2009;119(1):37-43. Hundemer GL, Agharazii M, Madore F, et al. Subclinical primary aldosteronism and cardiovas...
193
39
39
91f6274486c4d242d3af27d7611b4840487d6279008d4c0253cbf812b3d51645
Relationship between renin, aldosterone, aldosterone-to-renin ratio and arterial stiffness and left ventricular mass index in young adults. Circulation . 2024; 150(25):2019-2030. Liu YY, King J, Kline GA, et al.
61
39
39
f03de7d8d569c9daf7b29e550adb0a1af12d89d801dcaac80f86cd5444b52858
Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism. JAMA Surg . 2021;156(6):541-549. Yang J, Fuller PJ, Stowasser M. Is it time to screen all patients with hypertension for primary aldosteronism? Med J Aust . 2018; 209(2):57-59. Wu VC, Wang SM, Huang KH, et al.
90
39
39
f9bbaf4697fb4326de969545f14acda5a14b045db772ee5db53f644558066583
Long-term mortality and car - diovascular events in patients with unilateral primary aldosteronism after targeted treatments. Eur J Endocrinol . 2021;186(2):195-205. Sato M, Morimoto R, Seiji K, et al.
56
39
39
6beb5f3ca0ba0e45f90200188a6a75290e1ea04e6cb4d0699de6476f61e4aba0
Cost-effectiveness analysis of the diagnosis and treatment of primary aldosteronism in Japan. Horm Metab Res . 2015;47(11):826-832. Li N, Huang J, Zheng B, Cai H, Liu M, Liu L. Cost-effectiveness analysis of screening for primary aldosteronism in China. Clin Endocrinol (Oxf) . 2021;95(3):414-422. Woode ME, Wong K, Reid...
128
39
39
c617b22151e30592b254ad017bb618b9d348294b424cb5a87d9d161c2d498306
a markov modelling analysis. J Hypertens . 2023; 41(10):1615-1625. Nainani AK, Yang J, Peters S, Russell G. ‘ I can ’ t understand why others don ’ t screen more ’ : a qualitative study exploring why Australian general practitioners screen for primary aldosteronism. BMJ Open . 2022;12(6):e061671. Ananda RA, Gwini SM, L...
155
39
39
07ba75e724e91761a1945701c134860c4a31f077add1afab83f2331628b44113
Performance of the aldosterone-to-renin ratio as a screening test for primary aldoster - onism in primary care. Endocrine . 2022;77(1):11-20.
41
39
39
7af455e547b54e963834311c286b27ad815c6a213ecf3283eceef21c35afb25a
Shah SS, Zhang J, Gwini SM, Young MJ, Fuller PJ, Yang J. Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension:
43
39
39
518890bfe6327e0c9ce200c5b89dec40694a0129bc9d163bc25d9d0bf71ced58
a systematic review and meta-analysis. J Hum Hypertens . 2024;38(5):383-392. Buffolo F, Pecori A, Reincke M, et al.
41
39
39
40b953a876228952559e229a81865c4749efc4eb86cbd239617ae18dfa687d4b
Long-term follow-up of pa - tients with elevated aldosterone-to-renin ratio but negative con - firmatory test: the progression of primary aldosteronism phenotypes. Hypertension . 2024;81(2):340-347.
56
39
39
031dce636fa141ad9218746fbf41231bbfd0317b15dbd78a7a85eb95de7d59d9
Martinez-Aguayo A, Aglony M, Campino C, et al. Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population.
46
39
39
466a1502d542776810e4c911a84cff11809162ee9165ac58609e610203193227
Hypertension . 2010;56(3):391-396. Genovesi S, Antolini L, Orlando A, et al. Aldosterone-to-renin ra - tio depends on age and sex in children attending a clinic for cardio - vascular risk assessment.
57
39
39
0b0ba4b2000f8b3df571fc6a74dd7ec1e53ae00118a4fcced8f8e74dd77100e4
J Hypertens . 2018;36(2):344-352. Forestiero V, Sconfienza E, Mulatero P, Monticone S. Primary al - dosteronism in pregnancy. Rev Endocr Metab Disord . 2023; 24(1):39-48. Monticone S, Auchus RJ, Rainey WE. Adrenal disorders in preg - nancy. Nat Rev Endocrinol . 2012;8(11):668-678. Eisenhofer G, Durán C, Cannistraci CV,...
121
39
39
4f99b057ff0ecb039c7634d5fa36a3a7dce6fb515a58988bccce687289625cdf
Use of steroid pro - filing combined with machine learning for identification and sub - type classification in primary aldosteronism. JAMA Netw Open . 2020;3(9):e2016209. Reel PS, Reel S, van Kralingen JC, et al. Machine learning for classi - fication of hypertension subtypes using multi-omics: a multi-centre, retrospe...
180
39
39
cc7f40316fb4fc8ae95ae700cbda1821b0def704e973d071d1deba31119f19b3
Subtype diagnosis, treatment, complications and outcomes of primary The Journal of Clinical Endocrinology & Metabolism , 2025, Vol. 110, No. 9 2491 Downloaded from https://academic.oup.com/jcem/article/110/9/2453/8196671 by University of Wisconsin System user on 20 February 2026
73
39
39
1838192c4036080569f51ba73a95498abf0788ee36eb37cc39d61b9f7af54e1b
aldosteronism and future direction of research: a position state - ment and consensus of the working group on endocrine hyperten - sion of the European Society of Hypertension. J Hypertens . 2020; 38(10):1929-1936. Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldoster...
86
40
40
43fc8186565584bfa2f17d85dbd1e7ff330aaf7b64a692a8eb3cc2f6f18029e5
an inter - national consensus on outcome measures and analysis of remis - sion rates in an international cohort. Lancet Diabetes Endocrinol . 2017;5(9):689-699. Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med . 2008;168(1):80-85. Mu...
101
40
40
e224ebb06694dbd5df44dfc326d52022df3325559deda930e57faf76f89e63fe
Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab . 2013;98(12):4826-4833. Williams TA, Burrello J, Sechi LA, et al.
56
40
40
aa67b922a528d3c70d605308df25e313890918d7aa87268493d6190e5b655525
Computed tomography and adrenal venous sampling in the diagnosis of unilateral pri - mary aldosteronism. Hypertension . 2018;72(3):641-649. Mulatero P, Stowasser M, Loh KC, et al.
56
40
40
e05f19045ae57eb8c5ead9b82ad128cfd699e38b6dc60edae508bde9527bfe01
Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab . 2004; 89(3):1045-1050.
43
40
40
54cededcf74619f07952ac38257af3c049cf85415a01f715659a076e3d893bb2
Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism among unselected hyperten - sive patients:
49
40
40
8b11d87d1300edceff401a0d1178cc242c897aea3a2290d9237b17c28cacdcef
a prospective study based on the use of an aldoster - one/renin ratio above 25 as a screening test. Hypertens Res . 2007; 30(2):111-117. Kubo H, Tsurutani Y, Inoue K, et al.
58
40
40
6b6dab9f8323e284b973eba21f0d19400fab3c42ff53d74bdc54ca06d0607a39
Characteristics of aldosterone-producing adenomas in patients without plasma re - nin activity suppression. PLoS One . 2022;17(4):e0267732. Li X, Goswami R, Yang S, Li Q.
49
40
40
feeecf93bc0642f6b6d89bb5a503d5a50b42ffb3c6b46a507270f59eb0852ec9
Aldosterone/direct renin concen - tration ratio as a screening test for primary aldosteronism: a meta- analysis. J Renin Angiotensin Aldosterone Syst . 2016;17(3): 1470320316657450. Maciel AAW, Freitas TC, Fagundes GFC, et al.
75
40
40
60a9a4a2a60939c3551e2751f7e1953a28849426a28edb2db8ac4447207bf456
Intra-individual variability of serum aldosterone and implications for primary al - dosteronism screening. J Clin Endocrinol Metab . 2023;108(5): 1143-1153. Liu Z, Deng X, Luo L, et al.
55
40
40
b01642d1c5d0545175e43e90b81b7a2c92d7a38b1033a46621342dfc77df2e54
Diagnostic value of aldosterone to re - nin ratio calculated by plasma renin activity or plasma renin con - centration in primary aldosteronism: a meta-analysis. Chin Med J (Engl) . 2022;135(6):639-647.
59
40
40
122f5bd96cec4a7551c1de338317337fc8b2707ab978ae6b38737d66556aab30
Suntornlohanakul O, Sakarin S, Kietsiriroje N, Sriplung H. Geographical inequality in service utilization for primary aldoster - onism screening: spatial epidemiological study in southern Thailand. BMC Health Serv Res . 2022;22(1):458. Nainani A, Russell G, Yang J, Peters S.
76
40
40
8c667dc9c19a691dbe4d734b06c91e6a667a171085cc5d5155cc4f178ee0f1dc
General practitioner per - spectives and experiences when screening for primary aldosteron - ism in hypertensive patients. Ann Fam Med . 2022;20(20 Suppl 1): 3178. Li X, Liang J, Hu J, et al. Screening for primary aldosteronism on and off interfering medications. Endocrine . 2024;83(1):178-187. Pilz S, Keppel MH, Trumm...
95
40
40
df5f02f350f6a96c7ec008016199d1889b92458809ad6657288dea6cde870020
Diagnostic accuracy of the aldosterone-to-active renin ratio for detecting primary aldosteron - ism. J Endocr Soc . 2019;3(9):1748-1758. Stowasser M, Ahmed AH, Cowley D, et al.
59
40
40
fc563c987e55e0395a8cf3f2ead216ecb03638015a513b8040454e96bb3e9dc7
Comparison of seated with recumbent saline suppression testing for the diagnosis of pri - mary aldosteronism. J Clin Endocrinol Metab . 2018;103(11): 4113-4124. Guo Z, Poglitsch M, McWhinney BC, et al.
63
40
40
227f0960058ecab174486a4d433be28bb5e940e8dcc21adce93b8ec24744ee9f
Aldosterone LC-MS/ MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism. J Clin Endocrinol Metab . 2018;103(11):3965-3973. Thuzar M, Young K, Ahmed AH, et al.
61
40
40
7eb5e3c025c03b7961a9e283affeef9f66bf89cf4305a6dddbf0a41b32edf79b
Diagnosis of primary al - dosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS/MS. J Clin Endocrinol Metab . 2020;105(3):e477-e483.
52
40
40
7efd0bad62933262152d1d2677ae1e9f4014c54e5c414340bda02d73d5136c48
Brown JM, Auchus RJ, Honzel B, Luther JM, Yozamp N, Vaidya A. Recalibrating interpretations of aldosterone assays across the physiologic range:
42
40
40
55f8d8fb201155e1ba99ff84ca5d87695d76f0ae703ef9594f193f5cb8e35b4e
immunoassay and liquid chromatography- tandem mass spectrometry measurements under multiple con - trolled conditions. J Endocr Soc . 2022;6(6):bvac049.
41
40
40
b1cc69a1e223d1960080b3d3ae720faf204d907a60c128a137b418065e3433b5
Vaidya A, Morlote M, Moussa M, Barletta J, Nehs M. Targeting a hormonal cause of hypertension. N Engl J Med . 2025;392(4): Eisenhofer G, Kurlbaum M, Peitzsch M, et al. The saline infusion test for primary aldosteronism: implications of immunoassay in - accuracy. J Clin Endocrinol Metab . 2022;107(5):e2027-e2036. Leung ...
216
40
40
7cb16e64f6292ed780de3de0ccffe8dd05dc466c83eec5ab385e07bfc9f4989b
Kline GA, Pasieka JL, Harvey A, So B, Dias VC. High-probability features of primary aldosteronism may obviate the need for con - firmatory testing without increasing false-positive diagnoses.
52
40
40
df1d38a1cbd1e52d4ad16849560ae5f25e9336d82886e685cefdb888c05420b8
J Clin Hypertens (Greenwich) . 2014;16(7):488-496. Mulatero P, Monticone S, Deinum J, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism:
52
40
40
589f7eb64578514c14ec72cd915253cf1b2cedbf6f2e054b7938d67d5570e447
a position statement and consensus of the working group on endocrine hyper - tension of the European Society of Hypertension. J Hypertens . 2020;38(10):1919-1928. Naruse M, Katabami T, Shibata H, et al.
57
40
40
d1e26133b8e9ad57f9a12f40e51d57c7d1234ba121fbdca5df5dafa6ed87d517
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J . 2022;69(4):327-359. Morera J, Reznik Y. MANAGEMENT OF ENDOCRINE DISEASE:
55
40
40
075dff6c5d0c51d7e205515fa0ac962ec2dda005329fc4d242cc7f7ff28187ef
the role of confirmatory tests in the diagnosis of pri - mary aldosteronism. Eur J Endocrinol . 2019;180(2):R45-R58. Song Y, Yang S, He W, et al. Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study. Hypertension . 2018;71(1):118-124. Ahmed AH, Cowley D, Wolley M, et al...
200
40
40
4922bc18613bc5788679a193b3b2852708890a379e6c3d65e60ef8c98841e73f
Treatment of primary al - dosteronism and reversal of renin suppression improves left ven - tricular systolic function. Front Endocrinol (Lausanne) . 2022; 13:916744. Velema M, Dekkers T, Hermus A, et al. Quality of life in primary al - dosteronism: a comparative effectiveness study of adrenalectomy and medical treatme...
121
40
40
b5458288a3b9fe263aced4bbece15a8e21150da509d611e2d2494cf4c9475836
Adrenal vein sampling ver - sus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol . 2016;4(9):739-746. Pan CT, Liao CW, Tsai CH, et al.
62
40
40
b6d648f999d91deaa422e7de21e227310bdfae030e8dc557d0c88fb5f41c2062
Influence of different treatment strategies on new-onset atrial fibrillation among patients with pri - mary aldosteronism: a nationwide longitudinal cohort-based study. J Am Heart Assoc . 2020;9(5):e013699.
54
40
40
30d4ab580558e0df9ed2f53d68e8f312c330598cbf1bf9eeb005a4bde5b94f18
Jeunemaitre X, Chatellier G, Kreft-Jais C, et al. Efficacy and toler - ance of spironolactone in essential hypertension. Am J Cardiol . 1987;60(10):820-825. Tang F, Loh LM, Foo RS, et al. Tolerability and efficacy of long- term medical therapy in primary aldosteronism. J Endocr Soc . 2021;5(11):bvab144. Bernini G, Bacc...
118
40
40
6d470ba696cf2168d6f86d115883b67ad153f9abdc37b22dc1ca532574d6b51f
Cardiovascular changes in pa - tients with primary aldosteronism after surgical or medical treat - ment. J Endocrinol Invest . 2012;35(3):274-280. Parthasarathy HK, Ménard J, White WB, et al.
56
40
40
24242871e20474e9e43982ebe3781a2307f1bfecc37bd0c695e7251dff0e7ccb
A double-blind, randomized study comparing the antihypertensive effect of eplere - none and spironolactone in patients with hypertension and evi - dence of primary aldosteronism.
44
40
40
bc2c76e3599d60bc1716f8ff4172abefa181e047205e94aabc2fc762e1f660d9
J Hypertens . 2011;29(5):980-990. Iwakura Y, Morimoto R, Kudo M, et al. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease 2492 The Journal of Clinical Endocrinology & Metabolism , 2025, Vol.
65
40
40
81a83fbe1ad82cdc0cbab72a8cdc32fc69a24d7a7a130c9a4ef4e5b543883c93
110, No. 9 Downloaded from https://academic.oup.com/jcem/article/110/9/2453/8196671 by University of Wisconsin System user on 20 February 2026
44
40
40
838dd5eb379613452959448b60e11bc1b5cf46655c5056a0432c7ee39628472d
after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab . 2014;99(5):1593-1598. Lubitz CC, Economopoulos KP, Sy S, et al.
50
41
41
6575ee928f96b2e745d97ea13846dd47c62f2acf09d0cbcacecf192b2cabc11d
Cost-effectiveness of screening for primary aldosteronism and subtype diagnosis in the resistant hypertensive patients. Circ Cardiovasc Qual Outcomes . 2015;8(6):621-630. Reimel B, Zanocco K, Russo MJ, et al.
59
41
41
bde4073ccbeaeca689d1548ba7d06078b14db44eb11af3402e69be17a710e9be
The management of aldosterone-producing adrenal adenomas — does adrenalectomy in - crease costs? Surgery . 2010;148(6):1178-1185; discussion 1185. Hawkins NM, Scholes S, Bajekal M, et al. Community care in England: reducing socioeconomic inequalities in heart failure. Circulation . 2012;126(9):1050-1057.
85
41
41
d30d6e091cdcdef9f4095b2af66acca18593d3c3248d8e40605adaa018ef0801
Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension . 1980;2(6):757-764. Lachaine J, Beauchemin C, Ramos E.
61
41
41
e11cb0b2cd7b457b8ff1d52eafd73e84ee47f887a830af1783a9a82357335c3c
Use, tolerability and compli - ance of spironolactone in the treatment of heart failure. BMC Clin Pharmacol . 2011;11(1):4. Nikrýnová Nguyen TMP, Štrauch B, Petrák O, et al.
60
41
41
fa3eefe4d956de931d8d6ad149faddd528ff8132818bea8ace52759ed5cae001
Adherence and blood pressure control in patients with primary aldosteron - ism. Blood Press . 2022;31(1):58-63. Ginzberg SP, Gasior JA, Kelz LA, et al. Adrenalectomy approach and outcomes according to surgeon volume. Am J Surg . 2024;229: 44-49.
71
41
41
de79be122deef9486145931bb1fcbcf3e7d66907561f7e82c624f101c870be7a
Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of uni - lateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab . 2009;94(7): 2437-2445. Williams TA, Gong S, Tsurutani Y, et al. Adrenal surgery for bi - lateral primary aldosteronism: an international ...
121
41
41
5358c466a7f12cf2559b6c81a04c31de61c8ee933c7ccae94f8f14942b7d106b
Szabo Yamashita T, Shariq OA, Foster TR, et al. Unilateral adre - nalectomy for primary aldosteronism due to bilateral adrenal dis - ease can result in resolution of hypokalemia and amelioration of hypertension.
60
41
41
036a65d652aee9d7bdcd58c41ba811441c613baec807d006a5bddea50f49cb89
World J Surg . 2023;47(2):314-318. Kempers MJ, Lenders JW, van Outheusden L, et al. Systematic re - view:
41
41
41
d704d36d6df1343661ee8cfe3c6aa4680921a4edecc78ebf969f0ad7e1f60d07
diagnostic procedures to differentiate unilateral from bilat - eral adrenal abnormality in primary aldosteronism. Ann Intern Med . 2009;151(5):329-337. Lim V, Guo Q, Grant CS, et al.
51
41
41
d984208f30147ba7536426a08e066004e61a328e0a3cc6d932679e99bbd229cd
Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary al - dosteronism. J Clin Endocrinol Metab . 2014;99(8):2712-2719. Ma D, Liu X, Zeng L, et al.
58
41
41
0ed5be1730aa09823b7dd4e1d4c466dbf7cbe852582c98534943035e583b8130
The role of adrenal venous sampling and computed tomography in the management of primary aldos - teronism. J Hypertens . 2021;39(2):310-317.
40
41
41
9f546ca3af745c92cacb32bea18d4a4a0519ae9265bd33b0bec3ab44ad7bee45
Gkaniatsa E, Sakinis A, Palmér M, Muth A, Trimpou P, Ragnarsson O. Adrenal venous sampling in young patients with primary aldosteronism. Extravagance or irreplaceable? J Clin Endocrinol Metab . 2021;106(5):e2087-e2095. Thiesmeyer JW, Ullmann TM, Stamatiou AT, et al.
94
41
41
0114ad146564e92a735f5bb00a5b6778f06fb6687af046d5de4e3b8f352005c2
Association of adrenal venous sampling with outcomes in primary aldosteronism for unilateral adenomas. JAMA Surg . 2021;156(2):165-171. Fang C, Dai J, Zhao J, et al.
50
41
41
78e3ac3f700764ee418be8bd62ae1b9cc90ee088604561cce18137e3e91ad500
Surgery based on computed tomog - raphy images might be feasible for primary aldosteronism patients with visible unilateral adenoma. J Clin Hypertens (Greenwich) . 2023;25(11):1001-1008. Rossi GP, Barisa M, Allolio B, et al.
66
41
41
da015ca9fe759bf99e627534c79020ab1b0350245e058a3afa41718288a83004
The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab . 2012;97(5): 1606-1614. Young WF, Stanson AW.
53
41
41
b42ca2f3c847527e14303a7d4db77dba3505cd2666f41df3056c4f8f885ed58f
What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf) . 2009;70(1):14-17.
44
41
41
1a7cb529703a10a3abfd057c7b639a2cb5e5fecd56d61d363eeaea0c6aa1e554
Arjani S, Bostonian TJ, Prasath V, Quinn PL, Chokshi RJ. Cost-effectiveness of adrenal vein sampling- vs computed tomography-guided adrenalectomy for unilateral adrenaloma in pri - mary aldosteronism.
57
41
41
498b51af25bd61dcf85c9cc30c6ae4973eeaa5e847ce93fdf413bb1cb66c433c
J Endocrinol Invest . 2022;45(10):1899-1908. Vonend O, Ockenfels N, Gao X, et al. Adrenal venous sampling. Hypertension . 2011;57(5):990-995. Mohan S, Shariq OA, Andrews JC, Young WF Jr.
73
41
41
9d34767d796655654ccd52b322324bba8b72aadcc8ed96280169513ecf15aee9
Effect of cor - ticosteroid premedication on adrenal vein sampling in patients with primary aldosteronism and iodinated contrast media allergy. J Vasc Interv Radiol . 2025;36(4):594-600. Rossi GP, Auchus RJ, Brown M, et al.
64
41
41
eaf0f3118239e367dfef78e8a3a61371bdd2bf3521daf8043d67321aeb5d0405
An expert consensus state - ment on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension . 2014;63(1):151-160.
40
41
41
4c624b97597ba74fa71c1cb106a803f6c1932c894ea7b4a66f6c2688d91ecf64
Carr CE, Cope C, Cohen DL, Fraker DL, Trerotola SO. Comparison of sequential versus simultaneous methods of adrenal venous sampling. J Vasc Interv Radiol . 2004;15(11): 1245-1250. Elliott P, Holmes DT. Adrenal vein sampling: substantial need for technical improvement at regional referral centres. Clin Biochem . 2013;46...
107
41
41
f6acfa65bf07ff09c80224de87218b9c0fb15edc3aca51972dc8ed5e9379a807
Effect of adrenocortico - tropic hormone stimulation during adrenal vein sampling in pri - mary aldosteronism. Hypertension . 2012;59(4):840-846.
42
41
41
c038d7e71aaa5fc66e367ca503e2e1cdce0b5fdae2568cabae442d4c0ad027ce
Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary al - dosteronism. Surgery . 2004;136(6):1227-1235.
54
41
41
6ea62aa90b4d98baf80a3d96029ee631f1b42a7d8971ddd47e6a2b2c4a00302a
Rossi GP, Battistel M, Seccia TM, Rossi FB, Rossitto G. Subtyping of primary aldosteronism by adrenal venous sampling. Endocr Rev . 2025;163:789-795. Rossitto G, Amar L, Azizi M, et al. Subtyping of primary aldoster - onism in the AVIS-2 study: assessment of selectivity and lateraliza - tion. J Clin Endocrinol Metab . ...
128
41
41
3412619b9a31b564f5448cc9bbb04c6fece30e16598e0ae91eb80aeaa7d3bec8
Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism. Best Pract Res Clin Endocrinol Metab . 2020; 34(3):101400. Zhou Y, Zhang H, Luo J, et al.
55
41
41
6a23f223ca2ecd0aaf7452d01bccf83b0b3cdb6ed146dbf967cfa49b0c0fc309
Intraprocedural cortisol measure - ment increases adrenal vein cannulation success rate in primary al - dosteronism: a systematic review and meta-analysis. Am J Hypertens . 2024;37(2):134-142. Yozamp N, Hundemer GL, Moussa M, et al.
67
41
41
9565131ff087021fcf0dcf174697d7f5736fdf9b5796e0f8396b86053c9ecb1a
Intraindividual variability of aldosterone concentrations in primary aldosteron - ism: implications for case detection. Hypertension . 2021;77(3): 891-899. Takeda Y, Umakoshi H, Takeda Y, et al.
58
41
41
69a16a4b0809169294b2ac4b3d9357a22765b83ef5cc5b8e082a65af6762fb2d
Impact of adrenocortico - tropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism. J Hypertens . 2019;37(5): 1077-1082. Yatabe M, Bokuda K, Yamashita K, et al.
62
41
41
3329440ee1bf7c6b0c77580c7caf1ef9ee8c809ac2db42863ba22c56ac42a193
Cosyntropin stimula - tion in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism. Hypertens Res . 2020;43(10):1105-1112. Okubo J, Frudit P, Cavalcante A, et al.
70
41
41
e9ca968c4cdfa0ec026a4602adf4e85f5fec43ded22890f8c61a08045355068c
Contralateral suppression in adrenal venous sampling predicts clinical and biochemical out - come in primary aldosteronism. J Clin Endocrinol Metab . 2024; 109(9):2282-2293.
45
41
41
90e7c2b4345a8020cfe99e5dbc90cdc3f8b4abb39cfb090ae1d4c26ceaceb361
Desrochers MJ, St-Jean M, El Ghorayeb N, et al. Basal contralat - eral aldosterone suppression is rare in lateralized primary aldos - teronism.
46
41
41
3070ea02d5487d8e37fb60b01827d45a697c3b713f94fa77131e44565e4e2d85
Eur J Endocrinol . 2020;183(4):399-409. Nanba AT, Wannachalee T, Shields JJ, et al. Adrenal vein sam - pling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism.
60
41
41
a16b91cc7d32eae670c20106a4546f1489da86a1ab34781685e76ffb0d237001
J Clin Endocrinol Metab . 2019;104(2):487-492. Pintus G, Seccia TM, Amar L, et al. Subtype identification of sur - gically curable primary aldosteronism during treatment with min - eralocorticoid receptor blockade.
64
41
41
b6040fd2e09b51cfbb7658baab6e6fee997a3a2e53fc1f9167440d52297a6b71
Hypertension . 2024;81(6): 1391-1399. Jing Y, Hu J, Luo R, et al. Prevalence and characteristics of adrenal tumors in an unselected screening population: a cross-sectional study. Ann Intern Med . 2022;175(10):1383-1391. Umakoshi H, Ogasawara T, Takeda Y, et al.
85
41
41
2f98e36e8b042f3b11032b4a829c7e4dea0fd38ca3586b6e26a45f913725f662